Status:
COMPLETED
Knowledge and Practices of ADR Reporting in LMICs
Lead Sponsor:
Getz Pharma
Conditions:
Adverse Reaction
Eligibility:
All Genders
22+ years
Brief Summary
The reported literature suggests that knowledge about pharmacovigilance is on a lower side and ADR reporting is not common in developing countries. This survey may help us to identify the common gaps ...
Detailed Description
Safety evaluation of a product in a market is like a moving ball which need re-evaluation as the data gather in its life cycle.(1) As per the definition of International society of harmonization and W...
Eligibility Criteria
Inclusion
- \- Participants who would like to voluntarily fill the survey form
Exclusion
- Students
- Other than Health care professionals (including but not limited to Physicians, Doctors, Nurses and/or pharmacist)
Key Trial Info
Start Date :
April 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04301219
Start Date
April 1 2017
End Date
December 1 2018
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaheed Zulfiqar Ali Bhutto Medical University
Karachi, Sindh, Pakistan